ABECMA 260 - 500 x 1 000 000 cells, dispersion for infusion
Active ingredients: IDÉCABTAGÈNE VICLEUCEL
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Dispersion for infusion1 ou plusieurs poches EVA : éthylène vinyl acétate copolymère - Spécifique au patient, jusqu’à 100 mL,intraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ABECMA 260 - 500 x 1 000 000 cellules, dispersion pour perfusion
- Pharmaceutical form
- dispersion pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 ou plusieurs poches EVA : éthylène vinyl acétate copolymère - Spécifique au patient, jusqu’à 100 mL,
- Marketing authorisation holder
- BRISTOL-MYERS SQUIBB PHARMA (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Jan 2022
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Prescribed by specialists only
- Hospital use only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
65329132CIP75508498CIP133400955084983Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| IDÉCABTAGÈNE VICLEUCELdispersion | 260 - 500 x 1 000 000 cellules dans une ou plusieurs poches · 1 g de pommade rectale | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.